info@invisionmedi.com
V-BOSE-M2 Tablets
Obtain Supercilious Glycemic Control
COMPOSITION – Voglibose IP 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)
Description
- In a 24-week study on Korean patients with Type 2 DM and with inadequate glycemic control on diet and exercise, treatment with voglibose and metformin provided superior glycemic control for HbA1c, 2h-PPG, and FPG levels, greater weight loss, and less glycemic variability than did metformin monotherapy.
Composition
- Voglibose IP 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)
Related products
-
GLAMOR-PM Tablets
First-line Therapy with a Steady & Solid Combination to Manage Diabetes COMPOSITION – Glimepiride IP 2 mg + Metformin Hydrochloride IP 500 mg (SR) + Pioglitazone Hydrochloride IP 15 mg
-
ZIVALIO-10 Tablets
A Revolutionary Therapy to Control the Menace of T2DM COMPOSITION – Dapagliflozin 10 mg
-
REVOSART-40 Tablets
An Antihypertensive agent you can rely on unquestionably COMPOSITION – Telmisartan I.P. 40 mg
-
V-BOSE-GM2 – Tablets
An Abiding Antidiabetic combination for coherent Diabetic Control COMPOSITION – Glimepiride IP 2 mg+ Voglibose 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)